We are working hard to bring to you our new event series: Innovation in BioPharma & Digital health. We are now glad to announce that the inaugural event is scheduled for April 10, 2019 and our distinguished guest speaker is going to be Dr. Peter Bergethon, Head, Quantitative Medicine and Clinical Technologies at Biogen.
Join Alacrita at the CIC on January 29th, 2019, for an educational session on European drug development and commercialization. You will learn about valuable insight into most challenging aspects of the European drug development process.
Given the growth of the 66M caregivers in America, and the strong desire of families to age at home, caregivers are overwhelmingly burned out and under supported. 71% of caregivers are interested in using technology to support aging but only 7% of caregivers use technology. This presents a core problem in working with caregivers. Health care is difficult. We work in an industry where the payer (insurer), customer (clinician), distributor (pharmacy), and end user (patient or caregiver) are separate. Unsurprisingly, health care can feel siloed.
Changing health care is also difficult. Solutions may never find willing customers. Clinicians may have no incentive to try a new system on top of their already full workloads. Yet, with these challenges, there are moments when silos are broken down and scalable solutions are discovered: solutions that are beneficial for payers, beneficial for the health system, and most importantly beneficial for the patient.
Our vision for the inaugural Innovation in Caregiving Conference is to bring together an interdisciplinary group of health care professionals, such that silos are broken down, in order to uncover solutions centered around family and professional caregivers that have strong incentives for multiple health care stakeholders.
The target audience of the conference are payer, managed care, and health system executives looking for innovative solutions that work with caregivers to lower health care costs and the opportunity to learn about best practices in supporting caregivers. The target audience is also entrepreneurs, technologists, and investors interested in building or growing solutions in the caregiver space. Lastly, the target audience covers practitioners implementing solutions to support caregivers.
Bioverse Boston, is a meetup which focuses on educating individuals about 3D Bioprinting and bringing members of the Boston 3D Bioprinting community together! 3D Bioprinting is a highly interdisciplinary field, involving engineers, researchers, developers, physicians, mathematicians, and people passionate about reshaping the medical industry. If you fit this description, this meetup is for you, and we encourage you to join us!
Bioverse Boston is hosted by CELLINK in collaboration with Fab@CIC. CELLINK is the world's first bioink company which specializes in biocompatible bioinks and 3D bioprinters, passionate about revolutionizing the future of medicine through innovative technology. Fab@CIC is a creative space where people can connect, learn, and collaborate over a cup of coffee and a 3D printer; not just a digital fabrication cafe, but a hub for the local design and maker community that connects to a global business network.
Attendees need only bring an enthusiasm to learn more about the world of 3D Bioprinting (and a 21+ ID if planning to consume free alcoholic beverages!) Looking forward to seeing you all there.
RSVP at https://www.meetup.com/Bioverse-Boston-3D-Bioprinting-Meetup/events/vlkjqpyxjbrb/
Join MIT Hacking Medicine, LEO Pharma, Advancing Innovation in Dermatology and Hacking Medicine Institute for the first ever dermatology hackathon!
Did you know that it can take years for patients to be correctly diagnosed with conditions like psoriasis and eczema and that over 60% of all patients are not referred to a specialist correctly? Current treatment options are expensive and patients tend to have low adherence to medication. This is an area that is ripe for innovation in the pre competitive space.
Register now: visit hackingdermatology.org to learn about the challenge areas and apply to attend. On June 8-10, five grants of $5k will be awarded to the top teams. Following the first round of funding, up to $50k in additional grants will be awarded. Both preformed teams and individuals are invited to apply and attend.
FundRx is a New York based venture capital firm that invests in high impact healthcare and life science startups. On February 7th, Zeshan Muhammedi, CEO & Gurdane Bhutani, Managing Partner, of the FundRxteam will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.
FundRx believes deeply in supporting entrepreneurs, and has a community of over 2,000 physicians, scientists, and industry advisors who are available to support, mentor, and co-invest into its portfolio companies. Importantly, FundRx offers flexible, founder-friendly capital and rarely takes board seats -- we believe in letting great entrepreneurs run their own companies and in making sure we're only providing the support you want. Learn more at FundRx.com.
Within healthcare, FundRx is sector agnostic and looks at opportunities across the following industries:
- Medical Devices
- Healthcare IT
- Healthcare Services
Following the presentation, don't miss this opportunity to introduce yourself to the team during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with FundRx will provide an intimate forum to discuss your company.